Brought to you by 
Public offering nets $117.5mm for NeoGenomics
10 Aug 2018
Executive Summary
NeoGenomics Inc. netted $117.5mm through a public offering of 9.8mm common shares at $12.75. The company offers genetic testing for cancer and companion diagnostic/pharma services, and will use the offering proceeds for business growth and working capital.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
Laboratory Testing Services
- Anatomical Pathology
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Public offering nets $117.5mm for NeoGenomics
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice